International Journal of Molecular Medical Science, 2024, Vol.14, No.2, 48-55 http://medscipublisher.com/index.php/ijmms 55 Johnson T., Zhao L., Manuel G., Taylor H., and Liu D., 2019, Approaches to therapeutic angiogenesis for ischemic heart disease, J. Mol. Med. 97: 141-151. https://doi.org/10.1007/s00109-018-1729-3 PMid:30554258 PMCid:PMC6417498 Liao M.Q., and Guo S.X., Adeno-associated virus-based gene therapy for cardiovascular diseases, Shengming Kexue (Chinese Bulletin of Life Sciences), 3: 392-399. Li H.M., Yang C., 2020, Research progress of function and molecular mechanism of interleukin-37 in cardiovascular disease, Yixue Zongshu (Medical Recapitulate), 26(19): 3780-3784. Lu D., and Thum T., 2019, RNA-based diagnostic and therapeutic strategies for cardiovascular disease, Nat. Rev. Cardiol. 16: 661-674. https://doi.org/10.1038/s41569-019-0218-x PMid:31186539 Wang J., Kuang S.Q., 2023, The role of molecular biogenes in essential hypertension, Linchuang Yixue Jinzhan (Advances in Clinical Medicine), 13(7): 11036-11042. https://doi.org/10.12677/ACM.2023.1371539 Witkowski M., Weeks T.L., and Hazen S.L., 2020, Gut microbiota and cardiovascular disease, Circulation Research, 127(4): 553-570. https://doi.org/10.1161/CIRCRESAHA.120.316242 PMid:32762536 PMCid:PMC7416843 Zhang F., Xu D.D., Jiao X.D., Tao X., Wei H., Gao S.H., Hou X.Y., Li M.M., Wang Z.P., and Chen W.S., 2021, Advances of research on technologies for individualized treatment in clinical drug therapy, Yaoxue Jinzhan (Progress in Pharmaceutical Sciences), 45(2): 91-99.
RkJQdWJsaXNoZXIy MjQ4ODYzNQ==